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Abstract
Background: The development and progression of prostate cancer requires the transformation
of normal zinc-accumulating epithelial cells to malignant cells that have lost the ability to accumulate
zinc. This metabolic transformation is essential so that the tumor suppressive effects of zinc can be
eliminated and the malignant process can proceed. One of the major effects of zinc is its prevention
of prostate cell growth by its induction of apoptosis. The accumulation of cellular zinc has a direct
effect on the mitochondria that results in the release of cytochrome c, which initiates the caspase
cascade that leads to apoptosis. This effect is associated with the mitochondrial pore-forming
process, but the mechanism by which zinc induces the release of cytochrome c and induces
mitochondrial apoptogenesis has not been resolved. The present report provides for the first time
information that implicates Bax in the zinc induction of mitochondrial apoptogenesis.
Results: The effects of zinc treatment on the Bax levels of PC-3 cells and on the mitochondria
were determined. The exposure of isolated mitochondria to zinc results in an increase in
membrane bound Bax, which is due to the mitochondrial insertion of endogenous resident Bax.
The mitochondrial Bax/Bcl-2 ratio is increased by zinc treatment. Zinc treatment of PC-3 cells also
increases the mitochondrial level of Bax. In addition, zinc treatment increases the cellular level of
Bax and the cellular Bax/Bcl2 ratio. Down regulation of Bax in PC-3 cells eliminates the zinc
induction of apoptosis. The increase in cellular Bax level appears to involve zinc induction of Bax
gene expression.
Conclusion: This report extends and confirms that physiological levels of zinc induce apoptosis in
prostate cells. The study provides evidence that zinc is directly involved in facilitating a Bax-
associated pore formation process that initiates mitochondrial apoptogenesis. This is enhanced by
an additional effect of zinc on increasing the cellular level of Bax. To avoid the anti-tumor
apoptogenic effects of zinc, the malignant cells in prostate cancer posses genetic/metabolic
adaptations that prevent the cellular accumulation of zinc.
Background
An early event in the development and progression of
prostate cancer is the metabolic transformation of normal
zinc-accumulating epithelial cells to malignant cells that
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have lost the ability to accumulate zinc [for reviews see [1-
3]]. This metabolic transformation is essential so that the
tumor suppressive effects of zinc can be eliminated and
the malignant process can proceed. One of the effects of
zinc is the prevention of cell growth due to zinc-induced
apoptosis that occurs in prostate cells. In previous studies
[4-7], we reported that the uptake and accumulation of
zinc results in the mitochondrial release of cytochrome c,
which initiates the caspase cascade that leads to apoptosis.
Moreover, the release of cytochrome c results from a direct
and rapid interaction of cytosolic zinc with the mitochon-
dria; presumably through a zinc associated pore-forming
process. However, the mechanism by which zinc induces
the release of cytochrome c and induces mitochondrial
apoptogenesis has not been resolved. We now report that
zinc treatment of PC-3 cells facilitates the mitochondrial
insertion of Bax (i.e. a pore-forming activity); and also
increases the expression and cellular level of Bax.
Results
Direct effect of zinc on mitochondrial resident Bax
We previously demonstrated that exposure of isolated
prostate mitochondria to zinc results in the release of
cytochrome c [6,7]. Because of the role of Bax in the pore-
forming process for cytochrome c release [8,9], we deter-
mined the direct effect of zinc on the Bax level of isolated
mitochondria prepared from PC-3 cells. The mitochon-
dria were exposed to medium supplemented with 15 µM
zinc for 15 minutes or with unsupplemented medium
(control). The mitochondria were then subjected to alkali
treatment to remove weakly bound membrane Bax [9],
and assayed for Bax by Western blot. Zinc treatment
resulted in a significant 280% increase in mitochondrial-
bound Bax (Figure 1). As is the case with the release of
cytochrome c [7], the results demonstrate that zinc exhib-
its a direct effect on the mitochondria that does not
require the interaction or involvement of additional
cytosolic factors. The results also demonstrate that Bax is
a resident protein in the prostate mitochondria; i.e. it
exists in mitochondria of cells in the absence of an apop-
totic signal.
In some normal mammalian cells Bax is not found as a
resident mitochondrial protein [8], but is translocated to
the mitochondria from cytosol after the cells are exposed
to an apoptosis-inducing signal. Bax insertion into the
mitochondrial outer membrane is an initiating pore-
forming event in the release of cytochrome c that triggers
mitochondrial apoptogenesis [8-11].
Effect of zinc treatment on the levels of mitochondrial Bax 
and Bcl-2 in PC-3 cells
We then determined if the direct effect of zinc on Bax
observed in the isolated mitochondrial preparations also
occurred in PC-3 cells that were exposed to zinc-supple-
mented medium. PC-3 cells were exposed to medium sup-
plemented with 15 µM zinc for 180 minutes vs. no zinc
treatment. These are conditions that result in cytochrome
c release and pursuant apoptotic events [6,7]. The mito-
chondria were isolated and the Bax and Bcl-2 levels deter-
mined by Western blot. By 30 minutes of exposure to zinc,
the mitochondrial level of Bax was increased by about
100%; and further increased by 260% at 180 minutes
(Figure 2). Zinc treatment caused a much lower increase
in Bcl-2 that ranged from about 30% at 30 minutes to
80% by 180 minutes. Therefore, zinc treatment resulted in
a 2-fold increase in the Bax/Bcl-2 ratio. This is a relevant
relationship since it is generally recognized that mainte-
nance of an appropriate Bax/Bcl-2 balance in cells pre-
vents apoptosis [8,12]. When this ratio is altered in favor
of Bax, cells become apoptotic due to increased transloca-
tion of Bax to mitochondria and subsequent release of
cytochrome c.
Effect of zinc treatment on the cellular levels of Bax and 
Bcl-2 in PC-3 cells
The increase in mitochondrial Bax that results from expo-
sure of cells to zinc could be due to the translocation of
existing cytosolic Bax and/or an increase in the cellular
level of Bax. Therefore we determined the effect of 15 µM
zinc treatment on the total cellular levels of Bax and Bcl-2
in PC-3 cells. Figure 3 shows that the cellular level of Bax
was unchanged after three hours of zinc treatment; but by
six hours the Bax level increased by about 120% and fur-
ther increased to 180% by nine hours. In contrast, Bcl-2
exhibited only a slight increase of about 30% after nine
hours of zinc treatment. Therefore, the zinc treatment
caused the relative Bax/Bcl-2 ratio to increase from the
normalized pre-treatment ratio of 1/1 to ~2.5/1 following
treatment. It is also notable that up to three-hour zinc
treatment shown in Figure 3, caused no effect in total cel-
lular Bax; but caused a significant increase in mitochon-
drial Bax level within 30 minutes that markedly increased
by three hours. The rapidity of the increase in mitochon-
The direct effect of zinc on the level of bound Bax in isolated  mitochondria from PC-3 cells Figure 1
The direct effect of zinc on the level of bound Bax in 
isolated mitochondria from PC-3 cells. The isolated 
mitochondria were exposed to medium supplemented with 
15 µM zinc for 15 minutes or with unsupplemented medium 
(control).Molecular Cancer 2008, 7:25 http://www.molecular-cancer.com/content/7/1/25
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drial Bax that occurs prior to the increase in total cellular
Bax demonstrates that zinc has two effects: 1) it facilitates
the translocation of existing resident cytosolic Bax to
mitochondria; and 2) it facilitates an increase in total cel-
lular Bax level.
To corroborate further the linkage of the zinc-Bax-apopto-
sis relationship, we determined the effect of zinc on Bax
knock-down PC-3 cells. PC-3 cells were transfected with
Bax siRNA or with empty vector and cultured for 72 hours.
This was followed by treatment of the cells with 15 µM
zinc for 24 hrs. The cells were then collected for Western
blot analyses of Bax and microscopic examination. Figure
4 reveals that siRNA significantly decreased the level of
cellular Bax. Zinc treatment induced the expected apop-
totic effect in the control cells that expressed Bax; whereas
zinc treatment exhibited no apoptotic effect in the Bax-
deficient cells.
To obtain some initial insight into the mechanism associ-
ated with the increased cellular level of Bax, we deter-
mined the effect of cyclohexamide on the zinc-induced
increase in Bax. Figure 5 shows that zinc treatment, as
expected, increased the cellular level of Bax by about
150%. Cycloheximide treatment resulted in a 67% atten-
uation of the zinc effect. This provides initial evidence that
The effects of zinc on Bax and Bcl-2 levels of mitochondria  isolated from PC-3 cells that were exposed to medium sup- plemented with zinc Figure 2
The effects of zinc on Bax and Bcl-2 levels of mito-
chondria isolated from PC-3 cells that were exposed 
to medium supplemented with zinc. The cells were 
treated with medium supplemented with 15 µM zinc for 180 
minutes versus no zinc treatment.
The effect of 15 µM zinc treatment of PC-3 cells on the total  cellular levels of Bax and Bcl-2 Figure 3
The effect of 15 µM zinc treatment of PC-3 cells on 
the total cellular levels of Bax and Bcl-2.
The effect of zinc on Bax knock-down PC-3 cells Figure 4
The effect of zinc on Bax knock-down PC-3 cells. PC-3 
cells were transfected with Bax siRNA or with empty vector 
and cultured for 72 hours; followed by treatment of the cells 
with 15 µM zinc for 24 hours.
The effect of cyclohexamide treatment of PC-3 cells on the  zinc-induced cellular increase in Bax Figure 5
The effect of cyclohexamide treatment of PC-3 cells 
on the zinc-induced cellular increase in Bax. PC-3 cells 
were cultured in serum-free medium for 24 h and then 
treated with or without cycloheximide (CHX, 5 µg/ml) for 1 
hour prior to zinc (15 µM) exposure for 6 hours.Molecular Cancer 2008, 7:25 http://www.molecular-cancer.com/content/7/1/25
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cellular zinc accumulation might cause an increase in the
expression of the Bax gene, which would account for the
zinc-induced cellular increase in Bax.
Discussion
The results of this study confirm and extend our previous
reports [5-7] that zinc induces mitochondrial apoptogen-
esis in zinc-accumulating prostate cells. It is now evident
that zinc exhibits a direct effect on mitochondria that
facilitates the insertion of resident Bax, which is involved
in the mitochondrial pore-forming process [8,9,11]; and
is consistent with the release of cytochrome c that also
occurs in response to zinc treatment as we previously
reported (Figure 6). Other mechanisms of zinc-associated
apoptosis have been reported. For example, zinc-induced
Increased ROS production [13] and zinc involvement
with NF-kappaB [14] have been suggested to be associated
with the induction of apoptosis. These potential alterna-
tive mechanisms might be associated with zinc induced
apoptosis, but they are not required for or involved with
the direct Bax-associated mitochondrial apoptogenic
effect that we have identified. The conditions for the prep-
aration of the washed isolated mitochondrial prepara-
tions employed in this report and in our earlier reports
results in substrate-deficient non-respiring mitochondria
that eliminates any ROS production or any involvement
of intracellular signaling pathways.
That zinc treatment also induces an increase in cellular
Bax levels and in the Bax/Bcl-2 ratio would amplify the
zinc effect on mitochondrial Bax (Figure 6). The increase
in cellular Bax provides more Bax for translocation to the
mitochondria; and the increase in the Bax/Bcl-2 ratio
reduces the anti-apoptotic effect of Bcl-2. Zinc induction
of an increase in cellular Bax and in the Bax/BCL2 ratio
has been observed in other cells [15-17]. However, those
reports did not involve studies of direct effects of zinc on
mitochondria. It is important to add that we cannot dis-
miss the possible involvement of other proapoptotic pro-
teins that could be associated with a Bax pore forming
process; and such studies are important to pursue.
Although the cause of the increase in cellular Bax levels is
yet to be established, the attenuating effect of cyclohexa-
mide indicates a likely stimulatory effect of zinc on Bax
gene expression. A search of the promoter region of the
Bax gene reveals the absence of consensus MRE sequences.
Therefore a direct interaction with Metal-binding Tran-
scription Factor for activation of an MRE is not an availa-
ble option for an immediate-early Bax gene regulation by
zinc. However, several response elements for transcription
factors reportedly activated by zinc are present in the Bax
promoter [18,19]. Thus mechanisms involving zinc
induction of transcription factors with subsequent induc-
tion of Bax expression do exist and need to be investi-
gated.
The apoptogenic effect of zinc has important implications
in regard to prostate cancer [1-3]. The normal prostate
glandular epithelial cells evolved for the unique special-
ized capability and function of high zinc accumulation.
However, high cellular zinc levels have potential adverse
consequences on cellular activity: such as the metabolic/
bioenergetic effects of its inhibition of citrate oxidation
and truncation of the Krebs cycle; and the induction of
apoptosis. The normal prostate glandular epithelial cells
survive and function under these conditions due to their
incorporation and adaptation of conditions and activities
that compensate and modulate the potential adverse
effects of zinc. For example, the metabolic/bioenergetic
consequences are compensated by the incorporation of a
high aerobic glycolysis and an aspartate-glutamate-citrate
pathway, which normally do not exist in most mamma-
lian cells. In the case of the apoptotic effect, the normal
cells likely invoke anti-apoptotic activities. For example,
HIF-1a expression reportedly prevents the apoptotic effect
of zinc in normal prostate glands [13]. Our identification
of the role of Bax would suggest that the normal prostate
glandular epithelial cells likely incorporate upregulation
A representation of the integrated apoptogenic effects of  zinc Figure 6
A representation of the integrated apoptogenic 
effects of zinc. Zinc increases the Bax-associated mito-
chondrial pore forming process that results in the release of 
cytochrome c that initiates the caspase cascade leading to 
apoptosis. Zinc also increases the gene expression and cellu-
lar production of Bax and the Bax/Bcl-2 ratio, which facili-
tates the mitochondrial Bax-associated apoptogenic effect.Molecular Cancer 2008, 7:25 http://www.molecular-cancer.com/content/7/1/25
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of anti-apoptotic proteins such as Bcl-2 that prevent the
mitochondrial apoptogenic effects of zinc. This is an
important issue and relationship that needs to be pursued
Since the malignant cells are not functional specialized
glandular epithelial cells (they are parasitic cells), they
would not be expected to retain the specialized function
and capability of zinc accumulation; nor retain the protec-
tive mechanisms that prevent the adverse effects of zinc.
Consistent with this, it is now established that the high
zinc levels that characterize normal human glandular epi-
thelial cells are dramatically decreased in the epithelium
of adenocarcinomatous glands. The malignant cells in situ
lose the ability to accumulate zinc due to the down regu-
lation of the zinc uptake transporters, especially ZIP1
[20,21]. This releases the malignant cell from the apop-
totic effects of zinc; thereby allowing the growth/prolifer-
ation of malignancy. In the presence of the normally high
cellular zinc levels, the malignant cells would remain in
an arrested pre-malignant stage.
Unlike the in situ malignant prostate cells, PC-3 cells and
other malignant prostate cell lines do express ZIP1 and
the ability to accumulate zinc. When employed in the
xenograft tumorigenic model, zinc treatment of the ani-
mals results in an inhibition of tumor growth which is
accompanied by an increase in the tumor cell zinc accu-
mulation, an increase in apoptosis, and an increase in Bax
level and Bax/Bcl-2 ratio [22]. This provides evidence that
the in vitro apoptogenic effects of zinc are physiological as
well as clinical relevant effects of zinc. It is also notable
that zinc treatment exhibits apoptotic anti-tumor effects
in other cells [3,15-17,23]. These recent reports and the
effects of zinc on the cellular levels of Bax and induction
of apoptosis reported here support our proposal that zinc
is an tumor suppressor agent in prostate cancer and a
potential therapeutic agent for prostate cancer.
Conclusion
This report extends and confirms that zinc induces apop-
tosis in prostate cells. The study provides evidence that
zinc is directly involved in facilitating a Bax-associated
pore formation process. This provides a mechanism for
the release of cytochrome c [7], which initiates the caspase
cascade that leads to apoptosis. This effect is enhanced by
an additional action of zinc on increasing the cellular level
of Bax, possibly through an increase in the Bax gene
expression. The coordination of these effects is repre-
sented in Figure 6. In order to prevent the anti-tumor
apoptogenic effects of zinc, the malignant cells in situ in
prostate cancer invoke genetic/metabolic transformations
that prevent the cellular accumulation of zinc.
Methods
PC-3 Cell Culture and Zinc Treatment
The PC-3 malignant prostate cell line was obtained from
American Type Culture Collection (ATCC, Rockville,
MD), and were maintained in RPMI-1640 medium with
glutamine, and supplemented with 10% fetal bovine
serum (FBS) and 1% penicillin/streptomycin at 37°C in a
humidified atmosphere with 5% CO2. Generally, 24 h
before the treatment with zinc (15 µM), the growth
medium was replaced with serum free medium. The cells
were treated with zinc for variable times as indicated in
the Results. The cells were then used for isolation of mito-
chondria and/or preparation of total cellular protein. The
isolated mitochondria were subject for alkaline extrac-
tion.
Transfection of SIRNA of Bax to knock down the cellular 
Bax level
PC-3 cells were transfected with scrambled (control) or
with Bax siRNA (100 pmols/ml, Santa Cruz Biotech) and
cultured in growth medium for 48 h. Following another
24 h culture in serum-free medium, the cells were then
treated without or with zinc for 24 h. Cell proliferation
and apoptotic characteristics were examined under light
microscopy and the cellular level of Bax was determined
by Western Blot analyses.
Mitochondrial Preparation and zinc treatment of isolated 
mitochondria
PC-3 cells were harvested, and the mitochondria were iso-
lated under conditions as described previously [7]. The
protein concentration of the mitochondrial suspension
was measured by the method of Bradford [24]. Aliquots of
the suspension (100 µg of protein) were then were
employed in the reactions in the absence and presence of
added zinc (10 ng/µg mitochondrial protein) at 30°C for
15 min. At the end of the incubation, the mitochondria
were collected by rapid centrifugation at 10,000 × g for 5
min, and the mitochondrial pellets were then subjected to
alkaline extraction.
Alkali extraction of mitochondria and detection of Bax, 
Bcl-2 by Western Blot
For alkaline extraction, the mitochondrial pellets were re-
suspended (1 mg protein/ml) in freshly prepared 0.1 M
Na2CO3 (pH 11.5) and incubated for 20 min at 4°C [25].
The mitochondrial membranes were then collected by
centrifugation at 360,000 × g for 20 min at 4°C. The levels
of Bax and Bcl-2 in the samples were detected by Western
blot analyses as described previously [6]. Western blot
assays were conducted with specific antibodies for human
Bax (Santa Cruz Biotech) and for human Bcl-2 (BDBio-
sciences Pharmingen). The specificity of Bax signals recog-
nized by the antibody was further confirmed by the pre-
blocking experiment using Bax antibody. The amount ofPublish with BioMed Central    and   every 
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total cellular protein loaded for each sample was moni-
tored by the signals for β-actin used as an internal control;
mitochondrial protein CoxII was employed as the internal
control to adjust the loading amount of the mitochon-
drial samples. The intensities of specific bands were iden-
tified and recorded with an AlphaImager™2000 (Alpha
InnotechCorp.). All experiments reported herein were
repeated at least three times.
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